What is NP/PA marketing for pharma?

NP/PA marketing for pharma is the valuation, targeting, engagement and measurement of nurse practitioners and physician associates as prescribers for a pharmaceutical or biotechnology brand. SharePath values each clinician, finds the ones a brand plan is missing, reaches them through the brand's channels or its own, and measures prescription change at NPI level.

Does SharePath replace our existing agency, data provider or NP/PA vendor?

No. SharePath is data-agnostic and channel-agnostic. It works across the ecosystem already supporting the brand — the media agency still buys media, sales operations still owns the call plan, and the AOR still builds the campaign.

How does SharePath reach NPs and PAs?

Through the brand's own field, AOR and media partners, or through Health-Scripts — SharePath's own prescriber network, which delivers peer-signed email (Rounds), peer-presented video (Reels), in-office briefings (Curbsides) and speaker programs (Table Talks).

NP/PA Marketing for Pharma

What is your NP/PA opportunity worth?

Most brands can't answer that. We built a company that can.

Redefine your NP/PA outcomes → Talk with SharePath

Valuation. Targeting. Engagement. Measurement.

NPs and PAs aren't an emerging audience. They're an unpriced one.

What we do

Four stages. One continuous loop.

NP/PA Valuation

Know what each NP and PA is worth to the brand.

Forward value, current capture, and what's left.

NP/PA Targeting

Find the ones your plan is missing.

At NPI level — not by decile.

NP/PA Engagement

Reach them. Your channels or ours.

Field, AOR, media — or Health-Scripts^®.

NP/PA Measurement

Prove what moved.

NBRx and TRx at NPI level, against a matched control.

↻ Measurement feeds the next valuation

We work across your ecosystem — not instead of it.

Everyone keeps their seat. Everyone gets better intelligence.

DataSales OpsFieldCRM

→ SharePath ←

AORMediaDigitalEngagement

Independence

Independent by design.

Data-agnostic Channel-agnostic

Built to strengthen the commercial ecosystem already supporting your brand.

We don't find gaps. We close them.

Data

Clinicians missing or misclassified

NPI-level intelligence into the data environment

Sales Ops

High-opportunity clinicians off the call panel

Prioritized NPIs into planning and CRM

Media

Investment that doesn't match opportunity

Opportunity drives audience and budget

Engagement

High-opportunity cohorts under-engaged

Intelligence directs where engagement changes

When the answer is engagement

We own a channel. We will tell you when you don't need it.

Health-Scripts^® is our own network. Sometimes it's the right answer. Just as often the right answer is your field team, your AOR or your media partner — and we say so.

Digital

Rounds^™

Peer-signed email

Reels^™

Peer-presented video

Doorknocks

Curbsides^™

In-office briefings

Table Talks^™

Your speaker, our room

Visit Health-Scripts →

Every brand has a delta. Almost none can size it.

Clinical opportunity

What should be possible?

Commercial capture

How much is being addressed?

The delta

What remains?

We stay in our lane.

No generic market research.
No standalone advisory boards.
No CME.
No disconnected tactics.

If it isn't driven by our intelligence, it isn't a SharePath deliverable.

Back to where we started

NP/PA was where we started.

SharePath began with a singular focus on nurse practitioners and physician associates. As our business grew, so did our reach across the broader healthcare professional community.

But the clinical role of NPs and PAs continued to advance — and the need for sharper commercial focus only became more important.

So we're returning to our roots.

Today, SharePath is focused on helping pharmaceutical and biotechnology brands target, engage and measure NPs and PAs more effectively.

Now it's where we're going.

Leadership Team

Great medicines deserve a trusted path into clinical conversation.

Find your delta.

Redefine your NP/PA outcomes → Talk with SharePath